Literature DB >> 22610466

The Hunter syndrome-functional outcomes for clinical understanding scale (HS-FOCUS) questionnaire: evaluation of measurement properties.

Ingela Wiklund1, Mireia Raluy-Callado, Donald E Stull, Yvonne Jangelind, David A H Whiteman, Wen-Hung Chen.   

Abstract

PURPOSE: This study was to conduct the psychometric validation of the patient and parent versions of the Hunter syndrome-functional outcomes for clinical understanding scale (HS-FOCUS).
METHODS: Data collected in a 53-week placebo-controlled multinational trial were used to evaluate item performance and reliability, validity, and ability to detect change of the six HS-FOCUS function domains.
RESULTS: HS-FOCUS was completed by 49 patients above 12 years old and 84 parents. Floor effects and high average inter-item correlations suggested that some items were less informative or redundant. For both patients and parents, the internal consistency and test-retest reliability met the >0.70 criteria for all domains except for the breathing, sleeping, and schooling/work in patients. Construct validity showed moderate to high correlations with CHAQ, CHQ, and HUI3 in activity-related concepts. Significant differences in domain scores were found in most domains among severity in disability measured by CHAQ DIS. Significant differences in HS-FOCUS change scores were found in patients whose CHAQ DIS score also changed.
CONCLUSIONS: Psychometric validation of the HS-FOCUS demonstrates it is a reliable, valid, and responsive instrument that can be applied in clinical trials or disease registries. Findings on the individual item performance suggest some items could be removed without compromising its validity.

Entities:  

Mesh:

Year:  2012        PMID: 22610466     DOI: 10.1007/s11136-012-0196-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  17 in total

1.  Recommendations for evaluating the validity of quality of life claims for labeling and promotion.

Authors:  N K Leidy; D A Revicki; B Genesté
Journal:  Value Health       Date:  1999 Mar-Apr       Impact factor: 5.725

2.  Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation.

Authors:  Vassili Valayannopoulos; Jacques de Blic; Nizar Mahlaoui; Bertrand Stos; Francis Jaubert; Damien Bonnet; Alain Fischer; Pascale de Lonlay
Journal:  Pediatrics       Date:  2010-10-25       Impact factor: 7.124

3.  Preliminary definition of improvement in juvenile arthritis.

Authors:  E H Giannini; N Ruperto; A Ravelli; D J Lovell; D T Felson; A Martini
Journal:  Arthritis Rheum       Date:  1997-07

4.  The clinical meaning of functional outcome scores in children with juvenile arthritis.

Authors:  H Dempster; M Porepa; N Young; B M Feldman
Journal:  Arthritis Rheum       Date:  2001-08

5.  An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.

Authors:  M Rutten-van Mölken; B Roos; J A Van Noord
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

Review 6.  Multidisciplinary management of Hunter syndrome.

Authors:  Joseph Muenzer; M Beck; C M Eng; M L Escolar; R Giugliani; N H Guffon; P Harmatz; W Kamin; C Kampmann; S T Koseoglu; B Link; R A Martin; D W Molter; M V Muñoz Rojas; J W Ogilvie; R Parini; U Ramaswami; M Scarpa; I V Schwartz; R E Wood; E Wraith
Journal:  Pediatrics       Date:  2009-11-09       Impact factor: 7.124

Review 7.  Hearing Impairment in 2008: a compilation of available epidemiological studies.

Authors:  Donatella Pascolini; Andrew Smith
Journal:  Int J Audiol       Date:  2009       Impact factor: 2.117

8.  The natural history of the severe form of Hunter's syndrome: a study based on 52 cases.

Authors:  I D Young; P S Harper
Journal:  Dev Med Child Neurol       Date:  1983-08       Impact factor: 5.449

9.  A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B.

Authors:  Margaret M McGovern; Melissa P Wasserstein; Roberto Giugliani; Bruno Bembi; Marie T Vanier; Eugen Mengel; Scott E Brodie; David Mendelson; Gwen Skloot; Robert J Desnick; Noriko Kuriyama; Gerald F Cox
Journal:  Pediatrics       Date:  2008-07-14       Impact factor: 7.124

10.  Mild form of Hunter's syndrome: clinical delineation based on 31 cases.

Authors:  I D Young; P S Harper
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

View more
  8 in total

1.  Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.

Authors:  Julian Tanjuakio; Yasuyuki Suzuki; Pravin Patel; Eriko Yasuda; Francyne Kubaski; Akemi Tanaka; Hiromasa Yabe; Robert W Mason; Adriana M Montaño; Kenji E Orii; Koji O Orii; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

2.  The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life.

Authors:  Mireia Raluy-Callado; Wen-Hung Chen; David A H Whiteman; Juanzhi Fang; Ingela Wiklund
Journal:  Orphanet J Rare Dis       Date:  2013-07-10       Impact factor: 4.123

Review 3.  Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry.

Authors:  Joseph Muenzer; Simon A Jones; Anna Tylki-Szymańska; Paul Harmatz; Nancy J Mendelsohn; Nathalie Guffon; Roberto Giugliani; Barbara K Burton; Maurizio Scarpa; Michael Beck; Yvonne Jangelind; Elizabeth Hernberg-Stahl; Maria Paabøl Larsen; Tom Pulles; David A H Whiteman
Journal:  Orphanet J Rare Dis       Date:  2017-05-02       Impact factor: 4.123

4.  Diagnosis and follow-up of patients with Hunter syndrome in Spain: A Delphi consensus.

Authors:  Luis González-Gutiérrez-Solana; Encarnación Guillén-Navarro; Mireia Del Toro; Jaime Dalmau; Antonio González-Meneses; María L Couce
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

5.  Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS).

Authors:  Maria Mattera; Margaret K Vernon; Mireia Raluy-Callado; Jaromir Mikl
Journal:  Health Qual Life Outcomes       Date:  2018-11-08       Impact factor: 3.186

6.  Applying the functional independence measure to the assessment of patients with mucopolysaccharidosis.

Authors:  Marcos Almeida Matos; Paloma Silva Lopes; Allan Rodrigues Corsini; Julia Rodi; Chin-To Fong
Journal:  Colomb Med (Cali)       Date:  2020-09-30

7.  Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II.

Authors:  Karen S Yee; Yanyu Wu; Magdalena Harrington; Susan E Waisbren
Journal:  Orphanet J Rare Dis       Date:  2021-12-04       Impact factor: 4.123

8.  The Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) Questionnaire: item reduction and further validation.

Authors:  Ingela Wiklund; Mireia Raluy-Callado; Wen-Hung Chen; Joseph Muenzer; Juanzhi Fang; David Whiteman
Journal:  Qual Life Res       Date:  2014-05-08       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.